PIWIL4 and SUPT5H were identified and validated as novel prognostic biomarkers via bioinformatics and laboratory experiments, and a signature was developed to predict the prognosis and risk classifiers of ICC patients. This evidence concerns the gene PIWIL4 and intrahepatic cholangiocarcinoma.